The Patent Finder
US

Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating Cancer

US 12,221,433 In force
OverviewFamilyAssignmentsSources & methods

Term ends Jun 13, 2039 · Low confidence

Filed Jun 3, 2021 as application 17/338,368 · Granted Feb 11, 2025
Base term plus 822 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
20 years from filing
2019 2039
Clock starts
Jun 13, 2019
Term ends
Jun 13, 2039
Granted
Feb 11, 2025
base term Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
822
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 10,717,722, US 10,981,892.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 822 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 0 of 3 maintenance fees are paid so far. Confidence: Low. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jun 13, 2019, when application PCT/US2019/037067, the earliest non-provisional in its chain, was filed (this one was filed Jun 3, 2021); a parent in its chain could not be resolved (the next row)Jun 13, 2039High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustment+822 days, USPTO patent term adjustment recordSep 12, 2041High confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 10,717,722, US 10,981,892)capped to Jun 13, 2039Medium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events0 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderJun 13, 2039Low confidence

This family

Application PCT/US2019/037067PCT application
no patent term
no patent term
US 10,717,722In force
Jun 2039
Jun 2039
Application 16/888,197Abandoned
not computed
not computed
US 10,981,892In force
no later than Jun 2039
no later than Jun 2039
US 12,221,433this patent
Jun 2039
Jun 2039
Application 18/999,576Pending
not computed
not computed
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Aug 16, 2021
Reel 57188, frame 378
Beausoleil, Anne-marie; Hudson, RyanUnity Biotechnology, Inc.Assignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited